AstraZeneca PLC (AZN) Stock Overview
Explore AstraZeneca PLC’s financial performance, market position, analyst ratings, and future outlook.
AstraZeneca PLC (AZN)
Key Financials
Key Financials
Market Cap
131.2B
P/E Ratio
12.27
EPS (TTM)
$9.26
ROE
0.22%
AZN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of AstraZeneca PLC (AZN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 41.05, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $129.96.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 12.27 and a market capitalization of 131.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.